Monday, September 18, 2023

Dsychedelic Drug Closer to Approval

Naturenews reports on the psychedelic drug MDMA's effectiveness in treating PTSD.  A sample from the story:

The psychedelic drug MDMA, also known as ecstasy or molly, has passed another key hurdle on its way to regulatory approval as a treatment for mental illness. A second large clinical trial has found that the drug — in combination with psychotherapy — is effective at treating post-traumatic stress disorder (PTSD). The results allow the trial’s sponsor to now seek approval from the US Food and Drug Administration (FDA) for MDMA’s use as a PTSD treatment for the general public, which might come as soon as next year.

....In June, Australia became the first country to allow physicians to prescribe MDMA for treating psychiatric conditions. MDMA is illegal in the United States and other countries because of the potential for its misuse.

....MDMA doesn’t make the therapy process more “fun”, Mitchell says, but the drug seems to induce self-compassion in a way that other therapies don’t. She calls it “a communication lubricant” that helps people to recall traumatizing events and talk to their therapists without experiencing shame or horror.